BIOGEN INC. Available-for-sale Securities, Noncurrent
BIOGEN INC. (BIIB) had Available-for-sale Securities, Noncurrent of $1.41 billion as of 2019-12-31, per its 10-K filed 2020-02-06.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesNoncurrent · last filed 2020-02-06
- 2019-12-31: Available-for-sale Securities, Noncurrent $1.41B.
- 2018-12-31: Available-for-sale Securities, Noncurrent $1.38B.
- 2018-03-31: Available-for-sale Securities, Noncurrent $1.20B.
- 2017-12-31: Available-for-sale Securities, Noncurrent $3.06B.
| Period end | Available-for-sale Securities, Noncurrent | Available-for-sale Securities, Noncurrent as first filed |
|---|---|---|
| 2019-12-31 | $1.41B 10-K · filed 2020-02-06 | |
| 2018-12-31 | $1.38B 10-K · filed 2020-02-06 | |
| 2018-03-31 | $1.20B 10-Q · filed 2018-04-24 | |
| 2017-12-31 | $3.06B 10-K · filed 2019-02-06 | |
| 2017-09-30 | $3.06B 10-Q · filed 2017-10-24 | |
| 2017-06-30 | $2.63B 10-Q · filed 2017-07-25 | |
| 2017-03-31 | $2.83B 10-Q · filed 2017-04-25 | |
| 2016-12-31 | $2.83B 10-K · filed 2018-02-01 | |
| 2016-09-30 | $3.10B 10-Q · filed 2016-10-26 | |
| 2016-06-30 | $3.48B 10-Q · filed 2016-07-21 | |
| 2016-03-31 | $3.19B 10-Q · filed 2016-04-21 | |
| 2015-12-31 | $2.76B 10-K · filed 2017-02-02 | |
| 2015-09-30 | $1.95B 10-Q · filed 2015-10-21 | |
| 2015-06-30 | $2.10B 10-Q · filed 2015-07-24 | |
| 2015-03-31 | $1.38B 10-Q · filed 2015-04-24 | |
| 2014-12-31 | $1.47B 10-K · filed 2016-02-03 | $1.47B 10-K · filed 2015-02-04 |
| 2014-09-30 | $1.37B 10-Q · filed 2014-10-22 | |
| 2014-06-30 | $1.01B 10-Q · filed 2014-07-23 | |
| 2014-03-31 | $724.27M 10-Q · filed 2014-04-23 | |
| 2013-12-31 | $625.77M 10-K · filed 2015-02-04 | |
| 2013-09-30 | $373.56M 10-Q · filed 2013-10-28 | |
| 2013-06-30 | $107.14M 10-Q · filed 2013-07-25 | |
| 2012-12-31 | $2.04B 10-K · filed 2014-02-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |